These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

407 related items for PubMed ID: 23114438

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. High susceptibility of MDR and XDR Gram-negative pathogens to biphenyl-diacetylene-based difluoromethyl-allo-threonyl-hydroxamate LpxC inhibitors.
    Titecat M, Liang X, Lee CJ, Charlet A, Hocquet D, Lambert T, Pagès JM, Courcol R, Sebbane F, Toone EJ, Zhou P, Lemaitre N.
    J Antimicrob Chemother; 2016 Oct; 71(10):2874-82. PubMed ID: 27330072
    [Abstract] [Full Text] [Related]

  • 23. Transmission of carbapenem-resistant pathogens in New York City hospitals: progress and frustration.
    Landman D, Babu E, Shah N, Kelly P, Olawole O, Bäcker M, Bratu S, Quale J.
    J Antimicrob Chemother; 2012 Jun; 67(6):1427-31. PubMed ID: 22378678
    [Abstract] [Full Text] [Related]

  • 24. Carbapenem-resistant Gram-negative pathogens in a German university medical center: Prevalence, clinical implications and the role of novel β-lactam/β-lactamase inhibitor combinations.
    Katchanov J, Asar L, Klupp EM, Both A, Rothe C, König C, Rohde H, Kluge S, Maurer FP.
    PLoS One; 2018 Jun; 13(4):e0195757. PubMed ID: 29649276
    [Abstract] [Full Text] [Related]

  • 25. Novel multiplex PCRs for detection of the most prevalent carbapenemase genes in Gram-negative bacteria within Germany.
    Cerezales M, Biniossek L, Gerson S, Xanthopoulou K, Wille J, Wohlfarth E, Kaase M, Seifert H, Higgins PG.
    J Med Microbiol; 2021 Mar; 70(3):. PubMed ID: 33448924
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Antimicrobial activity of copper surfaces against carbapenemase-producing contemporary Gram-negative clinical isolates.
    Souli M, Galani I, Plachouras D, Panagea T, Armaganidis A, Petrikkos G, Giamarellou H.
    J Antimicrob Chemother; 2013 Apr; 68(4):852-7. PubMed ID: 23228934
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Antimicrobial resistance profile and associated factors of hospital-acquired gram-negative bacterial pathogens among hospitalized patients in northeast Ethiopia.
    Tilahun M, Sharew B, Shibabaw A.
    BMC Microbiol; 2024 Sep 11; 24(1):339. PubMed ID: 39261762
    [Abstract] [Full Text] [Related]

  • 31. Genetic analysis of carbapenemase-producing Gram-negative bacteria isolated from a university teaching hospital in Egypt.
    Soliman AM, Zarad HO, Nariya H, Shimamoto T, Shimamoto T.
    Infect Genet Evol; 2020 Jan 11; 77():104065. PubMed ID: 31634643
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Evaluation of the Amplidiag CarbaR+VRE Kit for Accurate Detection of Carbapenemase-Producing Bacteria.
    Oueslati S, Girlich D, Dortet L, Naas T.
    J Clin Microbiol; 2018 Mar 11; 56(3):. PubMed ID: 29305547
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Carbapenemases: molecular diversity and clinical consequences.
    Poirel L, Pitout JD, Nordmann P.
    Future Microbiol; 2007 Oct 11; 2(5):501-12. PubMed ID: 17927473
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.